RxDoctor Payments Data

Brian Gamble, MD

Diagnostic Radiology · Pomona, CANPI 1568478436

Payments from drug & device makers

$1,398in general payments, 2019–2025

Across 61 payments — averaging $22.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$489
  • Pfizer$129
  • Otsuka America Pharmaceutical, Inc.$123
  • Biohaven Pharmaceutical Holding Company Ltd.$110
  • Vanda Pharmaceuticals Inc.$98
  • Teva Pharmaceuticals USA, Inc.$82
  • plus $366 from 8 others

What the payments were for

  • Food & beverage$1,398100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,398 in reported general payments places this provider in the 85th percentile of 3,537 diagnostic radiology providers in California.

See all diagnostic radiology providers in California

Medicare billing

Part B allowed, 2024
$671,894
Medicare patients
571
Services billed
9,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metformin Er GastricMetformin Hcl45$132,313
Clemastine Fumarate13$104,502
OzempicSemaglutide57$56,558
JanuviaSitagliptin Phosphate53$56,465
Diclofenac Potassium22$54,065
Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate24$50,704
JardianceEmpagliflozin58$44,801
EliquisApixaban72$44,226
DescovyEmtricitabine/Tenofov Alafenam16$34,427
TivicayDolutegravir Sodium11$24,295
Cinacalcet Hcl24$24,273
XareltoRivaroxaban31$23,450
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$18,820
Lurasidone Hcl22$17,481
Combivent RespimatIpratropium/Albuterol Sulfate22$13,447

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$129$44,22672 claims
GileadDescovy$60$34,42716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,537 diagnostic radiology providers in California.

Other diagnostic radiology in Pomona

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →